Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 4, 2011, Pages 267-274

  Shao, Junfei ^a   Zheng, Donghui ^b   Jiang, Zhifeng ^a   Xu, Huae ^a   Hu, Yong ^c   Li, Xiaolin ^a   Lu, Xiaowei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

Curcumin; glioma; nanoparticle

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; MACROGOL DERIVATIVE; MONOMETHOXYPOLYETHYLENE GLYCOL; NANOPARTICLE; POLYCAPROLACTONE; POLYESTER;

ANIMAL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL LINE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; CYTOPLASM; DRUG DELIVERY SYSTEM; DRUG EFFECT; FLOW CYTOMETRY; GLIOMA; HEART MUSCLE CELL; IC 50; METABOLISM; METHODOLOGY; PATHOLOGY; RAT; SCANNING ELECTRON MICROSCOPY; TIME; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; CYTOPLASM; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; GLIOMA; INHIBITORY CONCENTRATION 50; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MYOCYTES, CARDIAC; NANOPARTICLES; POLYESTERS; POLYETHYLENE GLYCOLS; RATS; TIME FACTORS;

RATTUS;

EID: 79953224514     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr011     Document Type: Article

References (28)

1. American Cancer Society. Cancer Facts & Figures 2008. Atlanta, GA: American Cancer Society, 2008.
2. Fisher JL, Schwartzbaum JA, Wrensch M and Wiemels JL. Epidemiology of brain tumors. Neurol Clin 2007, 25: 867-890. (Pubitemid 47603275)
3. Fine HA, Dear KB, Loeffler JS, Black PM and Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993, 71: 2585-2597. (Pubitemid 23100496)
4. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2001, 359: 1011-1018. (Pubitemid 34286538)
5. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E and Dicato M, et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 2005, 223: 181-190. (Pubitemid 40719616)
6. Aggarwal BB, Kumar A and Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003, 23: 363-398. (Pubitemid 36361976)
7. Wang Z, Zhang Y, Banerjee S, Li Y and Sarkar FH. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 2006, 106: 2503-2513. (Pubitemid 43787677)
8. Maheshwari RK, Singh AK, Gaddipati J and Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci 2006, 78: 2081-2087.
9. Garcea G, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA and Steward WP, et al. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer 2004, 90: 1011-1015. (Pubitemid 38499692)
10. Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM and Boggs ME, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 2006, 6: 10-14.
11. Zheng D, Li X, Xu H, Lu X, Hu Y and Fan W. Study on docetaxel-loaded nanoparticles with high antitumor efficacy against malignant melanoma. Acta Biochim Biophys Sin 2009, 41: 578-587.
12. Shao J, Li X, Lu X, Jiang C, Hu Y, Li Q and You Y, et al. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloids Surf B Biointerfaces 2009, 72: 40-47.
13. Li X, Li R, Qian X, Ding Y, Tu Y, Guo R and Hu Y, et al. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Eur J Pharm Biopharm 2008, 70: 726-734.
14. Hu Y, Jiang X, Ding Y, Zhang L, Yang C, Zhang J and Chen J, et al. Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)- poly(ethylene oxide)-polylactide amphiphilic copolymer nano- particles. Biomaterials 2003, 24: 2395-2404. (Pubitemid 36434059)
15. Zhang L, Hu Y, Jiang X, Yang C, Lu W and Yang Y. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co- lactide) nano- particles and their biodistribution in mice. J Control Release 2004, 96: 135-148. (Pubitemid 38438496)
16. Gref R, Lueck M, Quellec P, Marchand M, Dellacherie E, Harnisch S and Blunk T, et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 2000, 18: 301-313. (Pubitemid 30479870)
17. Maeda H, Wu J, Sawa T, Matsumura Y and Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000, 65: 271-284. (Pubitemid 30122932)
18. Zambaux MF, Bonneaux F, Gref R, Dellacherie E and Vigneron C. MPEO-PLA nanoparticles: effect of MPEO content on some of their surface properties. J Biomed Mater Res 1999, 44: 109-115.
19. Manju S and Sreenivasan K. Synthesis and characterization of a cytotoxic cationic polyvinylpyrrolidone-curcumin conjugate. J Pharm Sci 2011, 100: 504-511.
20. Yallapu MM, Gupta BK, Jaggi M and Chauhan SC. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci 2010, 351: 19-29.
21. Herold DA, Keil K and Bruns DE. Oxidation of polyethylene glycol by alcohol dehydrogenase. Biochem Pharmacol 1989, 38: 73-76. (Pubitemid 19029156)
22. Richter AW and Akerblom E. Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol-modified proteins. Int Arch Allergy Appl Immunol 1983, 70: 124-131. (Pubitemid 13171427)
23. Perry MC, Demeule M, Régina A, Moumdjian R and Béliveau R. Curcumin inhibits tumor growth and angiogenesis in glioblastoma xeno- grafts. Mol Nutr Food Res 2010, 54: 1192-1201.
24. Luthra PM, Kumar R and Prakash A. Demethoxycurcumin induces Bcl-2 mediated G2/M arrest and apoptosis in human glioma U87 cells. Biochem Biophys Res Commun 2009, 384: 420-425.
25. Le Garrec D, Gori S, Luo L, Lessard D, Smith DC, Yessine MA and Ranger M, et al. Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation. J Control Release 2004, 99: 83-101. (Pubitemid 39165736)
26. Davda J and Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int J Pharm 2002, 233: 51-59. (Pubitemid 34230418)
27. van Vlerken LE, Duan Z, Seiden MV and Amiji MM. Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer. Cancer Res 2007, 67: 4843-4850. (Pubitemid 46910193)
28. 2-terminal kinase and caspase-3 by low doses of tetrandrine- loaded nanoparticles in Lovo cells - A possible Trojan strategy against cancer. Eur J Pharm Biopharm 2010, 75: 334-340.